The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.
15 August 2025
Amirose London Holdings PLC
(the "Company" or "Amirose")
Issue of Shares
Amirose London Holdings PLC is pleased to announce that it has raised gross proceeds of £30,000 from investors through the subscription of 600,000 new ordinary shares ("Subscription Shares") at the price of £0.05 per share ("Subscription Price") under existing unspent share authorities.
Application has been made for the Subscription Shares to be admitted to trading on the Aquis Stock Exchange Growth Market on or around 22 August 2025 ("Admission") and the Subscription Shares will rank pari passu with the ordinary shares of the Company in issue.
On Admission the Company will have 121,671,865 ordinary shares in issue, each ordinary share with one voting right. This number should be used by shareholders as the denominator for the calculation by which shareholders will determine if they are required to notify their interest in, or a change to their interest in the Company.
Aleksandra Binkowska, Non-Executive Chairman of Amirose , commented: " We are delighted to confirm the successful completion of this latest subscription, particularly the one which comes from a long-standing client with a highly successful brand that Amirose proudly manufactures. This investment is a strong vote of confidence in our partnership, our long-term strategy, and the new direction the company is taking. The capital raised will support key initiatives and open new avenues for growth."
For further information, please contact:
| Amirose London Holdings PLC Michael Heath Chief Executive Officer |
+44 7391 407 210 |
| Alfred Henry Corporate Finance ( Corporate Advisor) Nick Michaels/Maya Klein Wassink |
+44 (0) 20 8064 4056
|
| Capital Plus Partners Limited (Broker) Dominic Berger
|
+44 (0) 7799 888 544
|
| Novum Securities Limited (Broker) Jon Belliss/Colin Rowbury
|
+44 20 7399 9400
|
About Amirose London Holdings PLC
Amirose provides contract manufacturing services in the personal care sector for global and boutique premium brands. Amirose will assist such brands in developing formulations for personal care products, sourcing packaging, bulk manufacturing, filling and distributing. Amirose also helps customers navigate the regulatory and compliance framework required to bring a product to market. Amirose has approximately 75 customers and services over 200 brands. Amirose's manufacturing facilities are in Thetford, Norfolk. Amirose currently has 86 employees.
Amirose aims to transform its contract manufacturing business, which has so far generated modest profits while utilising only a portion of its factory's capacity, into a thriving enterprise by fully leveraging excess capacity, infrastructure, and the expertise of its team. Amirose expects to drive growth organically and through strategic acquisitions in the future.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.